Flushing

New Jersey American Water to Start Annual Spring Cleaning

Retrieved on: 
Tuesday, March 5, 2024

Beginning this week and into the fall months, New Jersey American Water will perform the annual flushing of its water distribution system to continue to provide customers with high-quality, reliable water service.

Key Points: 
  • Beginning this week and into the fall months, New Jersey American Water will perform the annual flushing of its water distribution system to continue to provide customers with high-quality, reliable water service.
  • While water mains are being cleaned, customers may notice short periods of low water pressure or discolored water.
  • If customers experience temporary water discoloration, New Jersey American Water recommends running the cold water until it is clear.
  • To learn more about New Jersey American Water’s 2024 hydrant flushing program, visit the Alerts page at www.newjerseyamwater.com .

China still remains world's largest engine for growth

Retrieved on: 
Thursday, February 29, 2024

China still remains the largest engine of global growth.

Key Points: 
  • China still remains the largest engine of global growth.
  • In 2023, China became the world's largest exporter of automobiles for the first time.
  • Borge Brende, president of the World Economic Forum, noted that China is shifting from investment- and infrastructure-driven growth to innovation-led growth, and it holds a crucial position in global economy and trade.
  • She believes that China's economic growth in 2024 will still surpass the global average, making China a major contributor to global economic growth in that year.

FDA Approves First Medication to Treat Severe Frostbite

Retrieved on: 
Wednesday, February 14, 2024

SILVER SPRING, Md., Feb. 14, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.

Key Points: 
  • SILVER SPRING, Md., Feb. 14, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.
  • Frostbite can occur in several stages, ranging from mild frostbite that does not require medical intervention and does not cause permanent skin damage, to severe frostbite when both the skin and underlying tissue are frozen and blood flow is stopped, sometimes requiring amputation.
  • Iloprost's efficacy in treating severe frostbite was primarily established in an open-label, controlled trial that randomized 47 adults with severe frostbite, who all received aspirin by vein and standard of care, into one of three treatment groups.
  • The two other groups received other medications that are unapproved for frostbite, given with iloprost (Group 2) or without iloprost (Group 3).

Ullo Launches Uno Wine Purifying Wands

Retrieved on: 
Thursday, February 8, 2024

CHICAGO, Feb. 8, 2024 /PRNewswire-PRWeb/ -- Ullo, the market leader in consumer wine purification, is adding wine purifying wands, called Uno, to its collection of solutions for removing sulfites from wine. Enabled by Ullo's patented Selective Sulfite™ technology, Uno wands are the newest and most advanced way to filter histamines and sulfites simply by swirling the Uno wand in your favorite glass of wine. The Uno wand selectively binds sulfites and histamines while gently aerating your wine to create a more flavorful and aromatic experience.

Key Points: 
  • CHICAGO, Feb. 8, 2024 /PRNewswire-PRWeb/ -- Ullo , the market leader in consumer wine purification, is adding wine purifying wands, called Uno , to its collection of solutions for removing sulfites from wine.
  • Enabled by Ullo's patented Selective Sulfite™ technology, Uno wands are the newest and most advanced way to filter histamines and sulfites simply by swirling the Uno wand in your favorite glass of wine.
  • The Uno wand selectively binds sulfites and histamines while gently aerating your wine to create a more flavorful and aromatic experience.
  • While Uno wine purifying wands are meant to work for one time use, Ullo understands the need to protect the micro-climates that produce the best wines in the world and the need to universally cut back on single-use products.

Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults1

Retrieved on: 
Friday, February 2, 2024

Napp Pharmaceuticals Limited, a member of the international network of Mundipharma independent associated companies, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised rezafungin for the treatment of invasive candidiasis in adults in Great Britain (GB).1,2

Key Points: 
  • Napp Pharmaceuticals Limited, a member of the international network of Mundipharma independent associated companies, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised rezafungin for the treatment of invasive candidiasis in adults in Great Britain (GB).1,2
    This press release features multimedia.
  • Common adverse reactions include anaemia, hypomagnesaemia, hypophosphataemia, hypotension, wheezing, vomiting, nausea, abdominal pain, constipation, erythema, and rash.
  • Increased blood alkaline phosphatase, hepatic enzymes, alanine aminotransferase, aspartate aminotransferase and blood bilirubin were also common.
  • Transient infusion-related reactions have occurred with rezafungin, characterised by flushing, sensation of warmth, nausea, and chest tightness.2
    Rezafungin may cause increased risk of phototoxicity.

Can you really be allergic to alcohol?

Retrieved on: 
Friday, January 5, 2024

Some people get allergy-like symptoms when drinking alcohol, but can you really be allergic to alcohol?

Key Points: 
  • Some people get allergy-like symptoms when drinking alcohol, but can you really be allergic to alcohol?
  • The reason is that alcohol dilates blood vessels, which then sets the stage for a symphony of bodily responses.
  • Unlike allergies, which involve the immune system, intolerances arise when the body lacks the necessary enzymes to digest and eliminate alcohol.
  • True allergic reactions stemming from yeasts are a rare occurrence, dampening the suspicion that this microscopic organism is the chief cause.

Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Date of authorisation: 15/11/2021, Revision: 5, Status: Authorised

Retrieved on: 
Friday, January 5, 2024

Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Date of authorisation: 15/11/2021, Revision: 5, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Date of authorisation: 15/11/2021, Revision: 5, Status: Authorised

Kura Sushi USA Announces Fiscal First Quarter 2024 Financial Results

Retrieved on: 
Thursday, January 4, 2024

IRVINE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial results for the fiscal first quarter ended November 30, 2023.

Key Points: 
  • IRVINE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial results for the fiscal first quarter ended November 30, 2023.
  • Comparable restaurant sales increased 3.8% for the first quarter of 2024 as compared to the first quarter of 2023.
  • During the fiscal first quarter of 2024, the Company opened four new restaurants in Pittsburgh, Pennsylvania; Flushing, New York; Tampa, Florida; and Naperville; Illinois.
  • Kura Sushi will host a fireside chat as part of the 26th Annual ICR Conference in Orlando, Florida on January 9, 2024.

Flushing Financial Corporation Announces Participation in The Microcap Conference

Retrieved on: 
Wednesday, January 3, 2024

Uniondale, New York--(Newsfile Corp. - January 3, 2024) - Flushing Financial Corporation (NASDAQ: FFIC) (the "Company"), the parent holding company for Flushing Bank (the "Bank"), will be participating in The Microcap Conference, which will take place January 30, 31, February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ.

Key Points: 
  • Uniondale, New York--(Newsfile Corp. - January 3, 2024) - Flushing Financial Corporation (NASDAQ: FFIC) (the "Company"), the parent holding company for Flushing Bank (the "Bank"), will be participating in The Microcap Conference, which will take place January 30, 31, February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ.
  • John R. Buran, President and Chief Executive Officer, and Susan K. Cullen, Senior Executive Vice President, Chief Financial Officer and Treasurer, will be presenting and conducting one-on-one meetings on January 31, 2024.
  • Interested parties can register to attend here .
  • To register to attend The Microcap Conference, follow this link .

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of authorisation: 30/01/2014, Revision: 29, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of authorisation: 30/01/2014, Revision: 29, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of authorisation: 30/01/2014, Revision: 29, Status: Authorised